To news
Mandates | 2022-05-31

TM & Partners has advised Vivesto in connection with a fully secured rights issue of SEK 151 million

TM & Partners has advised Vivesto AB in connection with a fully guaranteed rights issue of SEK 151 million. Danske Bank A/S, Sverige filial acted as financial adviser and Sole Bookrunner in connection with the rights issue.

Vivesto is a specialty pharmaceutical company focused on the development of new therapeutic options for patients suffering from hard-to-treat cancers. The company has proprietary drug delivery technology designed to improve solubility, efficacy and safety. Vivesto’s shares are listed on Nasdaq Stockholm.

TM & Partners’ team consisted of Johan Wigh (Partner), Jacob Elovsson Hultin (Associate), Philip Bihl (Associate) and Emily Frempomaa (Associate).

Cookie policy
TM & Partners

This website uses cookies in order to perform certain services and to help you as a user to navigate the site in an efficient manner. A cookie is a text file containing a small amount of information that is stored on your device provided your consent. For more information, please refer to Cookie Policy.

Necessary Cookies

Cookies necessary for remembering your cookie-preferences.

Performance cookies

Performance cookies are cookies used specifically for gathering data on how visitors use a website, which pages of a website are visited most often, or if they get error messages on web pages. These cookies monitor only the performance of the site as the user interacts with it. These cookies do not collect identifiable information on visitors, which means all the data collected is anonymous and only used to improve the functionality of a website.